Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study-Reference-Cited by-同舟云学术

Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study

Published:2023-01 Issue:1 Volume:23 Page:56-66
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Bardsley Megan,Morbey Roger A,Hughes Helen E,Beck Charles R,Watson Conall H,Zhao Hongxin,Ellis Joanna,Smith Gillian E,Elliot Alex J

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference24 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022

2. Respiratory syncytial virus seasonality: a global overview;Obando-Pacheco;J Infect Dis,2018

3. Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta-analysis;Zhang;J Infect Dis,2020

4. Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom;Goddard;Epidemiol Infect,2007

5. Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012;Reeves;Influenza Other Respir Viruses,2017

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogen characteristics of respiratory infections in the season after the COVID-19 pandemic between August and December 2023: evidence from direct-to-consumer testing-based surveillance in Guangzhou and Beijing, China;International Journal of Infectious Diseases;2024-10

2. Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection;Expert Review of Anti-infective Therapy;2024-09-13

3. The severity of respiratory syncytial virus infection in children during the SARS-CoV-2/COVID-19 pandemic: A nationwide study of 11,915 cases in Germany;Infection;2024-09-10

4. Respiratory infections in low and middle-income countries;Paediatric Respiratory Reviews;2024-09

5. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies;The Lancet;2024-09